Treatment Area
Face, Including the Submental Area Where Suitable
A facial-contouring treatment for concerns such as puffiness, submental fullness and reduced facial definition.
Cellbooster Shape is a minimally invasive injectable treatment designed to address localised fat deposits, puffiness and facial contour concerns. Developed in Switzerland by Suisselle, it uses patented CHAC Technology to deliver stabilised complexes of hyaluronic acid and selected active ingredients, supporting gradual improvements in facial definition.
Cellbooster Shape helps address localised fat accumulation and puffiness, particularly in areas where excess fullness affects facial definition.

Cellbooster Shape uses Suisselle's patented CHAC Technology, which links selected active ingredients to hyaluronic acid without chemical binding agents. This stabilised complex is designed to allow gradual delivery of active ingredients into the skin. The SHAPE formulation is intended to address localised fat deposits, puffiness and oedema while supporting microcirculation.
Face, Including the Submental Area Where Suitable
Approximately 30 minutes or less, depending on the treatment area.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging or temporary discomfort may occur during injection.
Minimal downtime is generally expected. Temporary redness, swelling, tenderness or bruising may occur at the injection sites.
An initial course of 3 sessions, spaced approximately 2–3 weeks apart, is recommended in the manufacturer's leaflet. Maintenance treatments may be advised according to individual response and medical assessment.
Improvements in facial puffiness and contour may develop gradually over the treatment course. Results vary depending on individual anatomy, treatment area and response.

A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous injectable treatments and any relevant health conditions.
Start with a consultation and discuss which treatment category may be relevant to your concern.
A facial-contouring treatment for concerns such as puffiness, submental fullness and reduced facial definition.
Cellbooster Shape is a minimally invasive injectable treatment designed to address localised fat deposits, puffiness and facial contour concerns. Developed in Switzerland by Suisselle, it uses patented CHAC Technology to deliver stabilised complexes of hyaluronic acid and selected active ingredients, supporting gradual improvements in facial definition.
Cellbooster Shape helps address localised fat accumulation and puffiness, particularly in areas where excess fullness affects facial definition.
Cellbooster Shape uses Suisselle's patented CHAC Technology, which links selected active ingredients to hyaluronic acid without chemical binding agents. This stabilised complex is designed to allow gradual delivery of active ingredients into the skin. The SHAPE formulation is intended to address localised fat deposits, puffiness and oedema while supporting microcirculation.
Face, Including the Submental Area Where Suitable
Approximately 30 minutes or less, depending on the treatment area.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging or temporary discomfort may occur during injection.
Minimal downtime is generally expected. Temporary redness, swelling, tenderness or bruising may occur at the injection sites.
An initial course of 3 sessions, spaced approximately 2–3 weeks apart, is recommended in the manufacturer's leaflet. Maintenance treatments may be advised according to individual response and medical assessment.
Improvements in facial puffiness and contour may develop gradually over the treatment course. Results vary depending on individual anatomy, treatment area and response.
A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous injectable treatments and any relevant health conditions.
A facial-contouring treatment for concerns such as puffiness, submental fullness and reduced facial definition.
Cellbooster Shape is a minimally invasive injectable treatment designed to address localised fat deposits, puffiness and facial contour concerns. Developed in Switzerland by Suisselle, it uses patented CHAC Technology to deliver stabilised complexes of hyaluronic acid and selected active ingredients, supporting gradual improvements in facial definition.
Cellbooster Shape helps address localised fat accumulation and puffiness, particularly in areas where excess fullness affects facial definition.
Cellbooster Shape uses Suisselle's patented CHAC Technology, which links selected active ingredients to hyaluronic acid without chemical binding agents. This stabilised complex is designed to allow gradual delivery of active ingredients into the skin. The SHAPE formulation is intended to address localised fat deposits, puffiness and oedema while supporting microcirculation.
Face, Including the Submental Area Where Suitable
Approximately 30 minutes or less, depending on the treatment area.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging or temporary discomfort may occur during injection.
Minimal downtime is generally expected. Temporary redness, swelling, tenderness or bruising may occur at the injection sites.
An initial course of 3 sessions, spaced approximately 2–3 weeks apart, is recommended in the manufacturer's leaflet. Maintenance treatments may be advised according to individual response and medical assessment.
Improvements in facial puffiness and contour may develop gradually over the treatment course. Results vary depending on individual anatomy, treatment area and response.
A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous injectable treatments and any relevant health conditions.
A facial-contouring treatment for concerns such as puffiness, submental fullness and reduced facial definition.
Cellbooster Shape is a minimally invasive injectable treatment designed to address localised fat deposits, puffiness and facial contour concerns. Developed in Switzerland by Suisselle, it uses patented CHAC Technology to deliver stabilised complexes of hyaluronic acid and selected active ingredients, supporting gradual improvements in facial definition.
Cellbooster Shape helps address localised fat accumulation and puffiness, particularly in areas where excess fullness affects facial definition.
Cellbooster Shape uses Suisselle's patented CHAC Technology, which links selected active ingredients to hyaluronic acid without chemical binding agents. This stabilised complex is designed to allow gradual delivery of active ingredients into the skin. The SHAPE formulation is intended to address localised fat deposits, puffiness and oedema while supporting microcirculation.
Face, Including the Submental Area Where Suitable
Approximately 30 minutes or less, depending on the treatment area.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging or temporary discomfort may occur during injection.
Minimal downtime is generally expected. Temporary redness, swelling, tenderness or bruising may occur at the injection sites.
An initial course of 3 sessions, spaced approximately 2–3 weeks apart, is recommended in the manufacturer's leaflet. Maintenance treatments may be advised according to individual response and medical assessment.
Improvements in facial puffiness and contour may develop gradually over the treatment course. Results vary depending on individual anatomy, treatment area and response.
A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous injectable treatments and any relevant health conditions.
A facial-contouring treatment for concerns such as puffiness, submental fullness and reduced facial definition.
Cellbooster Shape is a minimally invasive injectable treatment designed to address localised fat deposits, puffiness and facial contour concerns. Developed in Switzerland by Suisselle, it uses patented CHAC Technology to deliver stabilised complexes of hyaluronic acid and selected active ingredients, supporting gradual improvements in facial definition.
Cellbooster Shape helps address localised fat accumulation and puffiness, particularly in areas where excess fullness affects facial definition.
Cellbooster Shape uses Suisselle's patented CHAC Technology, which links selected active ingredients to hyaluronic acid without chemical binding agents. This stabilised complex is designed to allow gradual delivery of active ingredients into the skin. The SHAPE formulation is intended to address localised fat deposits, puffiness and oedema while supporting microcirculation.
Face, Including the Submental Area Where Suitable
Approximately 30 minutes or less, depending on the treatment area.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging or temporary discomfort may occur during injection.
Minimal downtime is generally expected. Temporary redness, swelling, tenderness or bruising may occur at the injection sites.
An initial course of 3 sessions, spaced approximately 2–3 weeks apart, is recommended in the manufacturer's leaflet. Maintenance treatments may be advised according to individual response and medical assessment.
Improvements in facial puffiness and contour may develop gradually over the treatment course. Results vary depending on individual anatomy, treatment area and response.
A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous injectable treatments and any relevant health conditions.
A facial-contouring treatment for concerns such as puffiness, submental fullness and reduced facial definition.
Cellbooster Shape is a minimally invasive injectable treatment designed to address localised fat deposits, puffiness and facial contour concerns. Developed in Switzerland by Suisselle, it uses patented CHAC Technology to deliver stabilised complexes of hyaluronic acid and selected active ingredients, supporting gradual improvements in facial definition.
Cellbooster Shape helps address localised fat accumulation and puffiness, particularly in areas where excess fullness affects facial definition.
Cellbooster Shape uses Suisselle's patented CHAC Technology, which links selected active ingredients to hyaluronic acid without chemical binding agents. This stabilised complex is designed to allow gradual delivery of active ingredients into the skin. The SHAPE formulation is intended to address localised fat deposits, puffiness and oedema while supporting microcirculation.
Face, Including the Submental Area Where Suitable
Approximately 30 minutes or less, depending on the treatment area.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging or temporary discomfort may occur during injection.
Minimal downtime is generally expected. Temporary redness, swelling, tenderness or bruising may occur at the injection sites.
An initial course of 3 sessions, spaced approximately 2–3 weeks apart, is recommended in the manufacturer's leaflet. Maintenance treatments may be advised according to individual response and medical assessment.
Improvements in facial puffiness and contour may develop gradually over the treatment course. Results vary depending on individual anatomy, treatment area and response.
A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous injectable treatments and any relevant health conditions.
A facial-contouring treatment for concerns such as puffiness, submental fullness and reduced facial definition.
Cellbooster Shape is a minimally invasive injectable treatment designed to address localised fat deposits, puffiness and facial contour concerns. Developed in Switzerland by Suisselle, it uses patented CHAC Technology to deliver stabilised complexes of hyaluronic acid and selected active ingredients, supporting gradual improvements in facial definition.
Cellbooster Shape helps address localised fat accumulation and puffiness, particularly in areas where excess fullness affects facial definition.
Cellbooster Shape uses Suisselle's patented CHAC Technology, which links selected active ingredients to hyaluronic acid without chemical binding agents. This stabilised complex is designed to allow gradual delivery of active ingredients into the skin. The SHAPE formulation is intended to address localised fat deposits, puffiness and oedema while supporting microcirculation.
Face, Including the Submental Area Where Suitable
Approximately 30 minutes or less, depending on the treatment area.
Topical anaesthesia may be applied before treatment to minimise discomfort. Mild stinging or temporary discomfort may occur during injection.
Minimal downtime is generally expected. Temporary redness, swelling, tenderness or bruising may occur at the injection sites.
An initial course of 3 sessions, spaced approximately 2–3 weeks apart, is recommended in the manufacturer's leaflet. Maintenance treatments may be advised according to individual response and medical assessment.
Improvements in facial puffiness and contour may develop gradually over the treatment course. Results vary depending on individual anatomy, treatment area and response.
A medical assessment is required before treatment. Inform your doctor of your medical history, current medications, allergies, previous injectable treatments and any relevant health conditions.